These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 1478344

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Animal virus contaminants of biotechnology products.
    Onions D.
    Dev Biol (Basel); 2004; 118():155-63. PubMed ID: 15645686
    [No Abstract] [Full Text] [Related]

  • 3. Introduction to the issues: viral vectors and potential problems in their use.
    Klinman DM.
    Dev Biol Stand; 1992; 76():299-300. PubMed ID: 1478347
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Validation of purification procedures for removing and/or inactivating viruses in biologicals: points to consider.
    Vicari G.
    Dev Biol Stand; 1991; 75():227-32. PubMed ID: 1794625
    [Abstract] [Full Text] [Related]

  • 9. Virological issues in the use of cell therapies.
    Minor PD.
    Dev Biol (Basel); 2004; 118():151-3. PubMed ID: 15645685
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes to biological source materials.
    Sewerin K, Shacter E, Robertson J, Wallerius C.
    Biologicals; 2006 Mar; 34(1):71-2. PubMed ID: 16480893
    [No Abstract] [Full Text] [Related]

  • 15. Viral safety evaluation of plasma-derived therapeutic products.
    Farshid M.
    Dev Biol (Basel); 2004 Mar; 118():11-5. PubMed ID: 15645668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability--FDA. Notice.
    Fed Regist; 1998 Sep 24; 63(185):51074-84. PubMed ID: 10185809
    [Abstract] [Full Text] [Related]

  • 19. Current issues in viral assays and viral clearance evaluation.
    Lubiniecki AS.
    Dev Biol Stand; 1996 Sep 24; 88():9-11. PubMed ID: 9119167
    [Abstract] [Full Text] [Related]

  • 20. Viral safety of biological products and the concept of validation.
    Horaud F.
    Dev Biol Stand; 1996 Sep 24; 88():19-24. PubMed ID: 9119135
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.